Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
伊沙妥昔单抗联合阿特珠单抗治疗晚期实体瘤患者：一项 I/II 期、开放标签、多中心研究的结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100562
Simonelli, M; Garralda, E; Eskens, F; Gil-Martin, M; Yen, C-J; Obermannova, R; Chao, Y; Lonardi, S; Melichar, B; Moreno, V; Yu, M-L; Bongiovanni, A; Calvo, E; Rottey, S; Machiels, J-P; Gonzalez-Martin, A; Paz-Ares, L; Chang, C-L; Mason, W; Lin, C-C; Reardon, D A; Vieito, M; Santoro, A; Meng, R; Abbadessa, G; Menas, F; Lee, H; Liu, Q; Combeau, C; Ternes, N; Ziti-Ljajic, S; Massard, C
